Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
277 Leser
Artikel bewerten:
(1)

Beautologie Cosmetic Surgery and Medical Aesthetics Specializes in Injectable Treatments and Fillers

BAKERSFIELD, CA / ACCESSWIRE / December 12, 2019 / Medical and technological advances in combination with a growing focus on quality of life have been driving the aesthetic procedures market, further supported by the increasing affordability of the most common beauty treatments and the improving effectiveness of the products. Among the most popular procedures are those involving injectables and dermal fillers as they deliver quick results and long-lasting effects. Global Market Insights estimates that dermal filler sales will surpass $8.5 billion by 2024, while Grand View Research projects that hyaluronic acid dermal fillers - the most popular solutions in the wrinkle removal category - will be a market worth $6.04 billion by 2025, expanding at a compound annual rate of 8.3%. California-based cosmetic surgery and medical aesthetics specialist Beautologie says there has been a surge in the number of people seeking to improve their appearance via non-invasive beautification procedures, and the company has earned an enviable reputation for delivering excellent results for patients who opt to undergo aesthetic treatments with injectables and dermal fillers.

There is an impressive choice of products that can rejuvenate the face, including popular injectable wrinkle relaxers Botox Cosmetic, Xeomin, Dysport, and Jeuveau and dermal fillers such as Restylane, Perlane/Restylane Lyft, and Juvederm. The latter group can be used in cases when patients require lip enhancement, deep creases smoothing, smoker lines diminishment, or cheekbones restoration. Aside from being highly effective, these products have long-lasting results, typically between six and 12 months. Dr. Darshan Shah, one of Beautologie's experts, notes, "The greatest thing about injectable procedures is that they can be done in the office and usually take about 20 to 30 minutes. The recovery time is generally very short - there might be a little bit of swelling, some redness, and an occasional bruise, but most of these things go away within a day or two."

Proven expertise in product application and thorough knowledge of the facial anatomy are crucial factors for achieving the desired results, Dr. Darshan Shah points out. "It is essential to seek out someone who knows what products and in what amounts to use to get not just a good but also a very nice natural result. I think it's important to look for a professional who has years of experience with these injectable treatments." Patients truly appreciate the personal touch and the effort Beautologie's specialists put into the whole process, investing sufficient time to get to know each client and suggesting the procedures and products that would work best in an individual case. Everything at the clinic is doctor-supervised or doctor-administered, in sharp contrast to the typical practices at medical spas or neighborhood salons, and patients greatly value this professional dedication, according to Dr. Shah.

Beautologie has become the destination of choice for Californians wishing to improve their physical appearance through cosmetic surgery or medical aesthetics procedures. Unrelentingly focused on patient comfort, quality work, and safety, the company has won multiple awards, among them the title of Best Bakersfield Plastic Surgeon (Dr. Darshan Shah) for 15 consecutive years. In addition to its team of highly trained doctors, Beautologie boasts fully AAAHC-accredited facilities and an unrivaled 100% safety record. Utilizing a collaborative approach, the company's specialists deliver the best possible care while ensuring that patients receive exemplary personalized treatment and experience the utmost satisfaction with the results.

Beautologie - Cosmetic Surgery and Medical Aesthetics in California: http://beautologienews.com
Beautologie (@beautologie) - Twitter: https://twitter.com/beautologie
Bakersfield Beautologie Has Been Voted Best 13 Years in a Row: https://www.drshah.com/bakersfield.html

Contact Information:
Beautologie
Michael Wittaker
mwhittaker@beautologie.com
https://www.beautologie.com
1-844-232-8865

SOURCE: Beautologie



View source version on accesswire.com:
https://www.accesswire.com/570015/Beautologie-Cosmetic-Surgery-and-Medical-Aesthetics-Specializes-in-Injectable-Treatments-and-Fillers

© 2019 ACCESS Newswire
Die USA haben fertig! 5 Aktien für den China-Boom
Die Finanzwelt ist im Umbruch! Nach Jahren der Dominanz erschüttert Donald Trumps erratische Wirtschaftspolitik das Fundament des amerikanischen Kapitalismus. Handelskriege, Rekordzölle und politische Isolation haben eine Kapitalflucht historischen Ausmaßes ausgelöst.

Milliarden strömen aus den USA – und suchen neue, lukrative Ziele. Und genau hier kommt China ins Spiel. Trotz aller Spannungen wächst die chinesische Wirtschaft dynamisch weiter, Innovation und Digitalisierung treiben die Märkte an.

Im kostenlosen Spezialreport stellen wir Ihnen 5 Aktien aus China vor, die vom US-Niedergang profitieren und das Potenzial haben, den Markt regelrecht zu überflügeln. Wer jetzt klug investiert, sichert sich den Zugang zu den neuen Wachstums-Champions von morgen.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche 5 Aktien die Konkurrenz aus den USA outperformen dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.